Lumen formation and other angiogenic activities of cultured capillary endothelial cells are inhibited by thrombospondin-1

Microvascular Research

Volumn 54, Issue 1, 1997, Pages 13-26

  Tolsma, Sara S ^a,b   Stack, M Sharon ^a   Bouck, Noël ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Northwestern College Orance City   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BASIC FIBROBLAST GROWTH FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE; GELATINASE; GLYCOPROTEIN; LEUPEPTIN; METALLOPROTEINASE; PEPSTATIN; SERINE PROTEINASE; THROMBOSPONDIN; TISSUE INHIBITOR OF METALLOPROTEINASE; UROKINASE;

ANIMAL CELL; ARTICLE; CAPILLARY ENDOTHELIUM; CATTLE; CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

ANIMALIA; BOS TAURUS;

EID: 0031193866     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1006/mvre.1997.2015     Document Type: Article

References (70)

1. Ades, E. W., Candal, F. J., Swerlick, R. A., George, V. G., Summers, S., Bosse, D. C., and Lawley, T.J. (1992). HMEC-1: Establishment of an immortalized human microvascular endothelial cell line. J. Invest. Dermatol. 99, 683-690.
2. Auerbach, R., Alby, L., Grieves, J., Joseph, J., Lindgren, C., Morrissey, L. W., Sidky, Y. A., Tu, M., and Watt, S. L. (1982). Monoclonal antibody against angiotensin-converting enzyme: Its use as a marker for murine, bovine, and human endothelial cells. Proc. Natl. Acad. Sci. USA 79, 7891-7895.
3. Bagavandoss, P., and Wilks, J. W. (1990). Specific inhibition of endothelial cell proliferation by thrombospondin. Biochem. Biophys. Res. Commun. 170, 867-872.
4. Bagavandoss, P., Kaytes, P., Vogeli, G., Wells, P. A., and Wilks, J. W. (1993). Recombinant truncated thrombospondin-1 monomer modulates endothelial cell plasminogen activator inhibitor 1 accumulation and proliferation in vitro. Biochem. Biophys. Res. Commun. 192, 325-332.
5. Ben Ezra, D., Griffin, B.W., Maftzir, G., and Aharonov, O. (1993). Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide. Invest. Opthalmol. Vis. Sci. 34, 3601-3608.
6. Bouck, N., Stellmach, V., and Hsu, S. (1996). How tumors become angiogenic. Adv. Cancer Res. 69, 135-174.
7. Bugge, T. H., Flick, M. J., Daugherty, C. C., and Degen, J. L. (1995) Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev. 9, 794-807.
8. Canfield, A. E., and Schor, A. M. (1995). Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells. J. Cell Sci. 108, 797-809.
9. Canfield, A. E., Schor, A. M., Schor, S. L., and Grant, M. E. (1986). The biosynthesis of extracellular-matrix components by bovine retinal endothelial cells displaying distinctive morphological phenotypes. Biochem. J. 235, 375-383.
10. Davis, G. E., and Camarillo, C. W. (1996). An α2β1 integrin-dependent pinocytotic mechanism involving intracellular vacuole formation and coalesence regulates capillary lumen and tube formation in three-dimensional collagen matrix. Exp. Cell Res. 224, 39-51.
11. Dawes, J., Clemetson, K. J., Gogstad, G. O., McGregor, J., Clezardin, P., Prowse, C. V., and Pepper, D. S. (1983). A radioimmunoassay for thrombospondin, used in a comparative study of thrombospondin, β-thromboglobulin and platelet factor 4 in healthy volunteers. Thrombosis Res. 29, 569-581.
12. DiPietro, L. A., Nebgen, D. R., and Polverini, P. J. (1994). Downregulation of endothelial cell thrombospondin 1 enhances in vitro angiogenesis. J. Vasc. Res. 31, 178-185.
13. Drake, C. J., Cheresh, D. A., and Little, C. D. (1995). An antagonist of integrin alpha v beta 3 prevents maturation of blood vessels during embryonic neovascularization. J. Cell Sci. 108, 2655-2661.
14. Folkman, J. (1995a). Tumor angiogenesis. In "The Molecular Basis of Cancer" (J. Mendelshon, P. M., Howley, M. A., Israel, and L. A. Liotta, Eds.), pp. 206-232. Saunders.
15. Folkman, J. (1995b). Clinical applications of research on angiogenesis. New Eng. J. Med. 333, 1757-1763.
16. Folkman, J., Haudenschild, C. C., and Zetter, B. R. (1979). Long-term culture of capillary endothelial cells. Proc. Natl. Acad. Sci. USA 76, 5217-5221.
17. Folkman, J., and Haudenschild, C. (1980). Angiogenesis in vitro. Nature 288, 551-556.
18. Frielander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A., and Cheresh, D. A. (1995). Definition of two angiogenic pathways by distinct αv integrins. Science 270, 1500-1502.
19. Gamble, J. R., Matthias, L. J., Meyer, G., Kaur, P., Russ, G., Faull, R., Berndt, M. C., and Vadas, M. A. (1933). Regulation of in vitro capillary tube formation by anti-integrin antibodies. J. Cell Biol. 121, 931-943.
20. Gao, A., Lindberg, F. P., Finn, M. B., Blystone, S. D., Brown, E. J., and Frazier, W. A. (1996). Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J. Biol. Chem. 271, 21-24.
21. Good, D. J., Polverini, P. J., Rastinejad, F., Le Beau, M. M., Lemons, R. S., Frazier, W. A., and Bouck, N. P. (1990). A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and func tionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA 87, 6624-6628.
22. Goto, F., Goto, K., Weindel, K., and Folkman, J. (1993). Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab. Invest. 69, 508-517.
23. Grant, D. S., Tashiro, K-I., Segui-Real, B., Yamada, Y., Martin, G. R., and Kleinman, H. K. (1989). Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell 58, 933-943.
24. Gradishar, W. J. (1996). An overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action. J. Invest. New Drugs, in press.
25. Gross, J. L., Moscatelli, D., Jaffe, E. A., and Rifkin, D. B. (1982). Plasminogen activator and collagenase production by cultured capillary endothelial cells. J. Cell Biol. 95, 974-981.
26. Gross, J. L., Moscatelli, D., and Rifkin, D. B. (1983). Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro. Proc. Natl. Acad. Sci. USA 80, 2623-2627.
27. Hanemaaijer, L., Koolwijk, P., Le Clercq, L., de Vree, W. J. A., and van Hinsbergh, V. W. M. (1993). Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Biochem. J. 296, 803-809.
28. Hogg, P. J. (1994). Thrombospondin 1 as an enzyme inhibitor. Thromb. Haemost. 72, 787-792.
29. Iruela-Arispe, M. L., Bornstein, P., and Sage, H. (1991). Thrombospondin exerts an anti-angiogenic effect on cord formation by endothelial cells in vitro. Proc. Natl. Acad. Sci. USA 88, 5026-5030.
30. Johnson, M. D., Kim, H-R. C., Chesler, L., Tsao-Wu, G., Bouck, N., and Polverini, P. J. (1994). Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J. Cell Phys. 160, 194-202.
31. Konerding, M. A., Steinberg, F., and Streffer, C. (1989). The vasculature of xenotransplanted human melanomas and sarcomas on nude mice. Acta. Anat. 136, 27-33.
32. Konerding, M. A., van Ackern, C., Steinberg, F., and Streffer, C. (1992a). The development of the tumor vasculature system: 2-D and 3-D approaches to network formation in human xenografted tumours. In "Angiogenesis in Health and Disease" (M. E. Maragoudakis, et al. Eds.), pp. 173-184. Plenum Press, New York.
33. Konerding, M. A., van Ackern, C., Steinberg, F., and Streffer, C. (1992b). Combined morphological approaches in the study of network formation in tumor angiogenesis. In "Angiogenesis: Key Principles" (R. Steiner, P. B. Weisz, and R. Langer, Eds.), pp. 40-58. Birkhauser Verlag Basel, Switzerland.
34. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
35. Lewalle, J. M., Munaut, C., Pichot, B., Cataldo, D., Baramova, E., and Foidart, J. M. (1995). Plasma membrane-dependent activation of gelatinase A in human vascular endothelial cells. J. Cell. Physiol. 165, 475-483.
36. Lingen, M. W., Polverini, P. J., and Bouck, N. P. (1996). Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic. Am. J. Pathol., in press.
37. Majack, R. A., Cook, S. C., and Bornstein, P. (1986). Control of smooth muscle cell growth by components of the extracellular matrix: Autocrine role for thrombospondin. Proc. Natl. Acad. Sci. USA 83, 9050-9054.
38. Mansfield, P. J., Boxer, L. A., and Suchard, S. J. (1990). Thrombospondin stimulates motility of human neutrophils. J. Cell Biol. 111, 3077-3086.
39. Mignatti, P., Tsuboi, R., Robbins, E., and Rifkin, D. B. (1989). In vitro angiogenesis on the human amniotic membrane: Requirement for basic fibroblast growth factor-induced proteinases. J. Cell Biol. 108, 671-682.
40. Moscatelli, D., and Rifkin, D. B. (1988). Membrane and matrix localization of proteinases: A common theme in tumor cell invasion and angiogenesis. Biochim. Biophys. Acta 948, 67-85.
41. Moser, T. L., Young, T. N., Rodriguez, G. C., Pizzo, S. V., Bast, R. C., and Stack, M. S. (1994). Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma. Int. J. Cancer 56, 552-559.
42. Moses, M. A., and Langer, R. (1992). Metalloproteinase inhibition as a mechanism for the inhibition of angiogenesis. In "Angiogenesis: Key Principles" (R. Steiner, P. B. Weisz, and R. Langer, Eds.), pp. 146-151. Birkhauster Verlag Basel, Switzerland.
43. Murphy-Ullrich, J. E., Schultz-Cherry, S., and Hook, M. (1992). Transforming growth factor-β complexes with thrombospondin. Mol. Biol Cell 3, 181-188.
44. Nicosia, R. F., and Tuszynski, G. P. (1994). Matrix-bound thrombospondin promotes angiogenesis in vitro. J. Cell Biol. 124, 183-193.
45. Pepper, M. S., Belin, D., Montesano, R., Orci, L., and Vassalli, J.-D. (1990). Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J. Cell Biol. 111, 743-755.
46. Pepper, M. S., Vassalli, J.-D., Orci, L., and Montesano, R. (1992). Proteolytic balance and capillary morphogenesis. In "Angiogenesis: Key Principles" (R. Steiner, P. B. Weisz and R. Langer, Eds.), pp. 137-145. Birkhauser Verlag, Basel, Switzerland.
47. Pepper, M. S., Sappino, A.-P., Stocklin, R., Montesano, R., Orci, L., and Vassalli, J.-D. (1993). Upregulation of urokinase receptor expression on migrating endothelial cells. J. Cell Biol. 122, 673-684.
48. Pepper, M. S., Vassalli, J.-D., Wilks, J. W., Schweigerer, L., Orci, L., and Montesano, R. (1994). Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis. J. Cell Biochem. 55, 419-434.
49. Prater, C. A., Plotkin, J., Jaye, D., and Frazier, W. A. (1991). The properdin-like type 1 repeats of human thrombospondin contain a cell attachment site. J. Cell Biol. 112, 1031-1040.
50. Presta, M., Rusnati, M., Maier, J. A. M., Urbinati, C., Sautuo, M., Gualandris, A., Pozzi, A., and Ragnotti, G. (1992). Basic fibroblast growth factor and endothelial cells: Receptor interaction, signal transduction, cellular response-dissociation of the mitogenic activity of bFGF from its plasminogen activator-inducing capacity. In "Angiogenesis in Health and Disease" (M. E. Maragoudakis, Ed.), pp. 79-89. Plenum Press, New York.
51. Rastinejad, F., Polverini, P. J., and Bouck, N. P. (1989). Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56, 345-355.
52. Ray, J. M., and Stetler-Stevenson, W. G. (1994). The role of matrix metalloproteases and their inhibitors in tumor invasion, metastasis and angiogenesis. Eur. Respir. J. 7, 2062-2072.
53. Ray Chaudhury, A., Frazier, W. A., and D'Amore, P. A. (1994). Comparison of normal and tumorigenic endothelial cells: Differences in thrombospondin production and responses to transforming growth factor-beta. J. Cell Sci. 107, 39-46.
54. Rogerson, F. M., Chai, S. Y., Schlawe, I., Murray, W. K., Marley, P. D., and Mendelsohn, F. A. O. (1992). Presence of angiotensin converting enzyme in the adventitia of large vessels. J. Hyperten. 10, 615-620.
55. Sato, N., Sawasaki, Y., Senoo, A., Fuse, Y., Hirano, Y., and Goto, T. (1987). Development of capillary networks from rat microvascular fragments in vitro: The role of myofibroblastic cells. Microvasc. Res. 33, 194-210.
56. Sheibani, N., and Frazier, W. A. (1995). Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis. Proc. Natl. Acad. Sci. USA 92, 6788-6792.
57. Stack, M. S., and Gray, R. D. (1989). Comparison of vertebrate collagenase and gelatinase using a new fluorogenic substrate peptide. J. Biol. Chem. 264, 4277-4281.
58. Sugawara, I., Hanada, H., Tsuruo, T., and Mori, S. (1990). Specialized localization of p-glycoprotein recognized by MRK 16 monoclonal antibody in endothelial cells of the brain and the spinal cord. Jpn. J. Cancer Res. 81, 727-730.
59. Taraboletti, G., Roberts, D., Liotta, L. A., and Giavazzi, R. (1990). Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: A potential angiogenesis regulatory factor. J. Cell Biol. 111, 765-772.
60. Taraboletti, G., Belotti, D., and Giavazzi, R. (1992). Thrombospondin modulates basic fibroblast growth factor activities on endothelial cells. In "Angiogenesis, Key Principles" (R. Steiner, P. B. Weiss, and R. Langer, Eds.), pp. 210-213. Birkhauser Verlag, Basel, Switzerland.
61. Tolsma, S. S. (1995). Inhibition of angiogenesis controlled by tumor suppressor genes: Thrombospondin-1 and its derived peptides. Thesis, Northwestern University, Evanston, IL.
62. Tolsma, S. S., Madsen, E. L., Chmeil, J., Martin, A. O., and Bouck, N. P. (1991). Diagnostic ultrasound is unable to enhance the rate of neoplastic transformation in cultured mammalian cells. J. Ultrasound Med. 10, 637-642.
63. Tolsma, S. S., Volpert, O. V., Good, D. J., Frazier, W. A., Polverini, P. J., and Bouck, N. (1993). Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J. Cell Biol. 122, 497-511.
64. Vassalli, J.-D., Dayer, J.-M., Wohlwend, A., and Belin, D. (1984). Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages. J. Exp. Med. 159,1653-1668.
65. Vogel, T., Guo, N-h., Krutzsch, H. C., Blake, D. A., Hartman, J., Mendelovitz, S., Panet, A., and Roberts, D. D. (1993). Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type 1 repeats of thrombospondin. J. Cell. Biochem. 53, 74-84.
66. Volpert, O. V., Tolsma, S. S., Pellerin, S., Feige, J.-J., Chen, H., Mosher, D. F., and Bouck, N. (1995). Inhibition of angiogenesis by thrombospondin-2. Biochem. Biophys. Res. Comm. 217, 326-332.
67. Weinstat-Saslow, D. L., Zabrentzky, V. S., VanHoutte, K., Frazier, W. A., Roberts, D. D., and Steeg, P. S. (1994). Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res. 54, 6504-6511.
68. Xu, Y., Swerlick, R. A., Sepp, N., Bosse, D., Ades, E. W., and Lawley, T. J. (1994). Characterization of expression and modulation of cell adhesion molecules on an immortalized human dermal microvascular endothelial cell line (HMEC-1). J. Invest. Dermatol. 102, 833-837.
69. Yabkowitz, R., Dixit, V. M., Guo, N., Roberts, D. D., and Shimizu, Y. (1993a) Activated T-cell adhesion to thrombospondin is mediated by the a4B1 (VLA-4) and a5B1 (VLA-5) integrins. J. Immunol. 151, 149-158.
70. Yabkowitz, R., Mansfield, P. J., Ryan, U. S., and Suchard, S. J. (1993b). Thrombospondin mediates migration and potentiates platelet-derived growth factor-dependent migration of calf pulmonary artery smooth muscle cells. J. Cell. Phys. 157, 24-32.